LAB vs. XLK
LAB (Standard Biotools Inc) is a stock, while XLK (State Street Technology Select Sector SPDR ETF) is Technology Equities fund tracking the S&P Technology Select Sector Daily Capped 35/20 Index. Over the past 3 years, LAB returned -26.56%/yr vs 30.61%/yr for XLK. At a 0.29 correlation, their price movements are largely independent.
Performance
LAB vs. XLK - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LAB achieves a -38.12% return, which is significantly lower than XLK's 28.25% return.
LAB
- 1D
- 2.34%
- 1M
- -23.10%
- YTD
- -38.12%
- 6M
- -47.02%
- 1Y
- -35.60%
- 3Y*
- -26.56%
- 5Y*
- —
- 10Y*
- —
XLK
- 1D
- -4.14%
- 1M
- 2.23%
- YTD
- 28.25%
- 6M
- 26.51%
- 1Y
- 52.47%
- 3Y*
- 30.61%
- 5Y*
- 21.34%
- 10Y*
- 25.48%
LAB vs. XLK - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
LAB Standard Biotools Inc | -38.12% | -26.86% | -20.81% | 88.89% | -71.11% |
XLK State Street Technology Select Sector SPDR ETF | 28.25% | 24.61% | 21.63% | 56.02% | -22.32% |
Correlation
The correlation between LAB and XLK is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.25 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Apr 5, 2022 | 0.29 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LAB vs. XLK — Risk / Return Rank
LAB
XLK
LAB vs. XLK - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Standard Biotools Inc (LAB) and State Street Technology Select Sector SPDR ETF (XLK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| LAB | XLK | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.78 | ||
| Sortino ratioReturn per unit of downside risk | -3.20 | ||
| Omega ratioGain probability vs. loss probability | 0.94 | 1.38 | -0.43 |
| Calmar ratioReturn relative to maximum drawdown | -0.66 | 3.31 | -3.97 |
| Martin ratioReturn relative to average drawdown | -1.32 | 10.56 | -11.88 |
Loading charts...
Drawdowns
LAB vs. XLK - Drawdown Comparison
The maximum LAB drawdown since its inception was -80.89%, roughly equal to the maximum XLK drawdown of -82.05%. Use the drawdown chart below to compare losses from any high point for LAB and XLK.
Loading charts...
Drawdown Indicators
| LAB | XLK | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -80.89% | -82.05% | +1.16% |
Max Drawdown (1Y)Largest decline over 1 year | -53.93% | -15.92% | -38.01% |
Max Drawdown (3Y)Largest decline over 3 years | -74.62% | -25.66% | -48.96% |
Max Drawdown (5Y)Largest decline over 5 years | — | -33.56% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.56% | — |
Current DrawdownCurrent decline from peak | -80.44% | -6.96% | -73.48% |
Average DrawdownAverage peak-to-trough decline | -56.52% | -34.90% | -21.62% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 26.97% | 4.98% | +21.99% |
Volatility
LAB vs. XLK - Volatility Comparison
Standard Biotools Inc (LAB) has a higher volatility of 43.07% compared to State Street Technology Select Sector SPDR ETF (XLK) at 12.51%. This indicates that LAB's price experiences larger fluctuations and is considered to be riskier than XLK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LAB | XLK | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 43.07% | 12.51% | +30.56% |
Volatility (6M)Calculated over the trailing 6-month period | 57.48% | 19.70% | +37.78% |
Volatility (1Y)Calculated over the trailing 1-year period | 69.16% | 23.48% | +45.68% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 82.18% | 25.37% | +56.81% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 82.18% | 24.71% | +57.47% |
Dividends
LAB vs. XLK - Dividend Comparison
LAB has not paid dividends to shareholders, while XLK's dividend yield for the trailing twelve months is around 0.43%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LAB Standard Biotools Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XLK State Street Technology Select Sector SPDR ETF | 0.43% | 0.54% | 0.66% | 0.76% | 1.04% | 0.65% | 0.92% | 1.16% | 1.60% | 1.37% | 1.74% | 1.79% |
Frequently Asked Questions
LAB and XLK have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LAB has higher volatility (43.07%) compared to XLK (12.51%). In terms of maximum drawdown, LAB dropped -80.89% vs XLK's -82.05%.
XLK currently has the higher Sharpe Ratio (2.25 vs -0.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LAB and XLK
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer